Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • Log out
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Short Communications

Is There Overlap Between the Genetic Determinants of Mammographic Density and Bone Mineral Density?

Gillian S. Dite, John D. Wark, Graham G. Giles, Dallas R. English, Margaret R.E. McCredie and John L. Hopper
Gillian S. Dite
1Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, The University of Melbourne, Australia, 2Department of Medicine, The University of Melbourne, Royal Melbourne Hospital, Australia, 3Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia; and 4Department of Preventive and Social Medicine, University of Otago, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John D. Wark
1Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, The University of Melbourne, Australia, 2Department of Medicine, The University of Melbourne, Royal Melbourne Hospital, Australia, 3Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia; and 4Department of Preventive and Social Medicine, University of Otago, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graham G. Giles
1Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, The University of Melbourne, Australia, 2Department of Medicine, The University of Melbourne, Royal Melbourne Hospital, Australia, 3Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia; and 4Department of Preventive and Social Medicine, University of Otago, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dallas R. English
1Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, The University of Melbourne, Australia, 2Department of Medicine, The University of Melbourne, Royal Melbourne Hospital, Australia, 3Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia; and 4Department of Preventive and Social Medicine, University of Otago, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margaret R.E. McCredie
1Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, The University of Melbourne, Australia, 2Department of Medicine, The University of Melbourne, Royal Melbourne Hospital, Australia, 3Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia; and 4Department of Preventive and Social Medicine, University of Otago, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John L. Hopper
1Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, The University of Melbourne, Australia, 2Department of Medicine, The University of Melbourne, Royal Melbourne Hospital, Australia, 3Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia; and 4Department of Preventive and Social Medicine, University of Otago, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-05-0279 Published September 2005
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Mammographic density and bone mineral density, risk factors for breast cancer and osteoporotic fractures, respectively, are both thought to reflect cumulative exposure to estrogen and are highly heritable. We asked if there was overlap between the genes that explain their variances. We studied 63 monozygous and 71 dizygous female twin pairs ages 38 to 71 years (mean, 50 years). Absolute and percent mammographic densities were measured by a computer-assisted method, and bone mineral density was measured at the lumbar spine, femoral neck, and forearm by dual energy X-ray absorptiometry. After adjusting for age, height, and weight, the within-person and cross-trait cross-twin correlations between the mammographic density and bone mineral density measures were between −0.09 and 0.16 (SEs, 0.07-0.09) and independent of zygosity (all P > 0.05). We conclude that there is little, if any, overlap between the genetic or environmental determinants of disease risk associated with these traits.

  • Mammographic density
  • bone mineral density
  • twin study
  • genetic epidemiology

Introduction

Mammographic density is the area of the two-dimensional representation of the breast on a mammogram that is radiographically dense and is presumed to represent connective and epithelial breast tissue. It is a well-established and strong risk factor for breast cancer, independent of age and other risk factors measured by questionnaires (1). Mammographic density itself can be changed by interventions involving hormones (2-4) and tamoxifen (5) and reproductive factors which affect exposure to endogenous estrogen and progesterone are associated with age-adjusted mammographic density (1). In premenopausal women, the proliferation of mammographic density is stimulated by estrogen and progesterone and is highest during the luteal phase of the menstrual cycle (6, 7). Therefore, it is possible that mammographic density is influenced by hormone-related risk factors for breast cancer. Furthermore, these factors are as yet unknown and may not be captured by questionnaire items that are presumed to be surrogates for exposure to hormones.

Bone mineral density is a two-dimensional measure of the attenuation of a weak X-ray beam through the body, is correlated with the amount of calcium in the bones, and is a risk factor for osteoporotic fractures (8). Estrogen plays an important part in the regulation of bone turnover, determination of peak bone mineral density, and age-related loss of bone mineral density (9). Bone mineral density has also been associated with reproductive factors that influence levels of endogenous estrogen, and decreases after menopause (9).

Both traits are highly heritable. Studies of twin pairs under the assumptions of the classic twin model suggest, and are supported by those of other close relatives, that genetic factors explain about 60% of the age-adjusted variance in mammographic density (10-14) and, depending on site, 50% to 80% of the age-adjusted variance in bone mineral density (15-19). Measurement error explains about 10% of mammographic density variance and <5% of bone mineral density variance, and the remainder is considered to be due to individual-specific environmental effects. We therefore asked if there was overlap in the genes that explain variation in these two traits.

Materials and Methods

We identified 63 monozygous and 71 dizygous female twin pairs who had participated in both a cross-sectional study of mammographic density conducted between 1995 and 1999 and a longitudinal study of bone mineral density conducted since 1990, recruited through the Australian Twin Registry and described in detail in Boyd et al. (13) for the mammographic density study and in MacInnis et al. (20) and Flicker et al. (21) for the bone mineral density study. Mammographic density was measured by a computer-assisted method (22) and bone mineral density by dual energy X-ray absorptiometry (8). The study protocols were approved by the Human Research Ethics Committees at The University of Melbourne (mammographic density study) and the Clinical Research and Ethics Committee at the Royal Melbourne Hospital (bone mineral density study). All twins provided written informed consent for participation in each study.

Data from the mammographic density study (age at mammogram, percent mammographic density, mammographic dense area, and self-reported height and weight) were merged with those from the bone mineral density study for the date closest to the date of mammography (age at bone scan, bone mineral density at the lumbar spine, femoral neck, and forearm, and measured height and weight). Twins were of ages 38 to 71 years (mean, 50; SD, 8). The mean absolute difference in age at measurement between the studies was 1.5 years (SD, 1.4).

The classic twin model decomposes the variance of a trait by considering the difference between, and relative magnitudes of, the trait correlations in monozygous and dizygous pairs. Under the assumption that the nongenetic determinants of the trait are shared within monozygous pairs to the same extent as they are shared within dizygous pairs, a greater correlation in monozygous pairs than in dizygous pairs is consistent with genetic factors explaining at least part of the trait variation (23). The model can be extended to assess whether the genetic determinants of one trait overlap with the genetic determinants of another trait. To do this, one tests whether the correlation between one trait in one twin and the other trait in the other twin (the cross-trait cross-twin correlation) is greater for monozygous pairs than for dizygous pairs (24).

Models were fitted according to maximum likelihood theory under a multivariate normal model using the software FISHER (25). We log transformed mammographic dense area. The trait means were modeled as functions of the relevant measures of age, height, and weight. In previous analyses, we fitted models for mammographic density and bone mineral density measures and found evidence for a genetic component and an individual specific environmental component for each trait (e.g., refs. 13, 19, 21). All statistical tests were two sided.

Results

Table 1 shows that neither percent mammographic density nor log mammographic dense area was correlated with any of the bone mineral density measures, within pairs or across pairs, or in either zygosity group. Stratification by menopausal status gave similar results for the 57 pairs both premenopausal and the 58 pairs both postmenopausal (data not shown). As an illustration, Fig. 1 shows the lack of association between the age-, height- and weight-adjusted standardized residuals for percent mammographic density and lumbar spine bone mineral density for both monozygous and dizygous pairs using cross-twin cross-trait scatterplots and scatterplots of the within-pair differences in the two traits which account fully for age and in part for other potential confounding factors.

View this table:
  • View inline
  • View popup
Table 1.

Adjusted estimates, SEs, and P values of the within-twin cross-trait correlations between mammographic density and bone mineral density for all pairs, and, the cross-twin cross-trait correlations for monozygous and dizygous pairs

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Cross-twin cross-trait scatterplots (A) and within-pair difference scatterplots (B) for the standardized residuals of age-, height-, and weight-adjusted percent mammographic density (PMD) versus lumbar spine bone mineral density (BMD) for monozygous and dizygous pairs.

Discussion

Recently, Kerlikowske et al. (26) reported on a cross-sectional study which also found no correlation within an individual between percent mammographic density and bone mineral density at the hip or spine, overall and within subgroups. Our twin study has supported their null finding within twins and also found no correlation across twins. We had 80% power to detect at 0.05 (two-tailed) a true correlation of more than 0.2 or less than −0.2.

There are both genetic and environmental determinants of variation in these two traits. Kerlikowske et al. (26) and our result of a null correlation between these two traits within an individual would not necessarily imply that there was no overlap of genetic factors; however, for that to be true, any association would have to be counteracted by individual-specific environmental factors (independent of zygosity) that act in the opposite direction in both traits so as to cause a negative (or positive) correlation between the two traits. However, because we observed no significant monozygous cross-trait cross-twin correlations, and no significant difference between monozygous and dizygous cross-trait cross-pair correlations, we conclude there is little, if any, overlap between the genetic, or environmental, determinants of disease risk associated with these traits. The absence of any correlation between these two traits may be due to the manner in which they are affected by estrogen exposure. Bone mineral density is related to cumulative estrogen exposure whereas increases in mammographic density occur during the luteal phase of the menstrual cycle.

Acknowledgments

We are indebted to the twins who participated in both these studies, Dr Norman Boyd, the Australian Twin Registry, and BreastScreen Australia.

Footnotes

  • Grant support: The mammographic density study was supported by the Kathleen Cuningham Foundation (now the National Breast Cancer Foundation) the Victorian Breast Cancer Research Consortium and the Merck Sharp and Dohme Research Foundation. The bone mineral density study was supported by the National Health and Medical Research Council, the Victorian Health Promotion Foundation, and the Helen M. Schutt Trust.

  • The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • Received April 20, 2005.
  • Revision received July 8, 2005.
  • Accepted July 19, 2005.
  • American Association for Cancer Research

References

  1. ↵
    Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ. Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998;7:1113–44.
    OpenUrl
  2. ↵
    Laya MB, Gallagher JC, Schreiman JS, Larson EB, Watson P, Weinstein L. Effect of postmenopausal hormone replacement therapy on mammographic density and parenchymal pattern. Radiology 1995;196:433–7.
    OpenUrlPubMed
  3. Vachon CM, Sellers TA, Vierkant RA, Wu F-F, Brandt KR. Case-control study of increased mammographic density response to hormone replacement therapy. Cancer Epidemiol Biomarkers Prev 2002;11:1382–8.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Greendale GA, Reboussin BA, Slone S, Waisilauskas C, Pike MC, Ursin G. Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst 2003;95:30–7.
    OpenUrlCrossRefPubMed
  5. ↵
    Cuzick J, Warwick J, Pinney E, Warren RML, Duffy SW. Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst 2004;96:621–8.
    OpenUrlCrossRefPubMed
  6. ↵
    White E, Velentgas P, Mandelson MT, et al. Variation in mammographic breast density by the time in menstrual cycle among women aged 40-49 years. J Natl Cancer Inst 1998;90:906–10.
    OpenUrlCrossRefPubMed
  7. ↵
    Ursin G, Parisky YR, Pike MC, Spicer DV. Mammographic density changes during the menstrual cycle. Cancer Epidemiol Biomarkers Prev 2001;10:141–2.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Blake GM, Fogelman I. DXA scanning and its interpretation in osteoporosis. Hosp Med 2003;64:521–5.
    OpenUrlPubMed
  9. ↵
    Wark JD. Osteoporotic fractures: background and prevention strategies. Maturitas 1996;23:193–207.
    OpenUrlCrossRefPubMed
  10. ↵
    Wolfe JN, Albert S, Belle S, Salane M. Familial influences on breast parenchymal patterns. Cancer 1980;46:2433–7.
    OpenUrlCrossRefPubMed
  11. Kapiro J, Alanko A, Kivisaari L, Standertskjold-Nordenstrom CG. Mammographic patterns in twin pairs discordant for breast cancer. Br J Radiol 1987;60:459–62.
    OpenUrlAbstract/FREE Full Text
  12. Pankow JS, Vachon CM, Kuni CC, et al. Genetic analysis of mammographic density in adult women: evidence of a gene effect. J Natl Cancer Inst 1997;89:549–56.
    OpenUrlCrossRefPubMed
  13. ↵
    Boyd NF, Dite GS, Stone J, et al. High heritability of percent mammographic density, a risk factor for breast cancer. New Engl J Med 2002;347:886–94.
    OpenUrlCrossRefPubMed
  14. ↵
    Ziv E, Shepherd J, Smith-Bindman R, Kerlikowske K. Mammographic breast density and family history of breast cancer. J Natl Cancer Inst 2003;95:556–8.
    OpenUrlCrossRefPubMed
  15. ↵
    Smith DM, Nance WE, Kang KW, Christian JC, Johnson CC, Jr. Genetic factors in determining bone mass. J Clin Invest 1973;52:2800–8.
    OpenUrlPubMed
  16. Dequecker J, Nijs J, Verstraeten A, Geusens P, Gevers G. Genetic determinants of bone mineral content at the spine and radius: a twin study. Bone 1987;8:207–9.
    OpenUrlPubMed
  17. Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, Eberl JA. Genetic determinants of bone mass in adults: a twin study. J Clin Invest 1987;80:706–10.
    OpenUrlCrossRefPubMed
  18. Krall EA, Dawson-Hughes B. Heritable and life-style determinants of bone mineral density. J Bone Miner Res 1993;8:1–9.
    OpenUrlPubMed
  19. ↵
    Hopper JL, Green RM, Nowson CA, et al. Genetic, common environment, and individual specific components of variance for bone mineral density in 10- to 26-year-old females: a twin study. Am J Epidemiol 1998;147:17–29.
    OpenUrlPubMed
  20. ↵
    MacInnis RJ, Cassar C, Nowson CA, et al. Determinants of bone density in 30- to 65-year-old women: a co-twin study. J Bone Miner Res 2003;18:1650–6.
    OpenUrlCrossRefPubMed
  21. ↵
    Flicker L, Hopper JL, Rodgers L, Kaymakci B, Green RM, Wark JD. Bone density determinants in elderly women: a twin study. J Bone Miner Res 1995;10:1607–13.
    OpenUrlPubMed
  22. ↵
    Byng JW, Yaffe MJ, Jong RA, et al. Analysis of mammographic density and breast cancer risk from digitized mammograms. Radiographics 1998;18:1587–98.
    OpenUrlCrossRefPubMed
  23. ↵
    Hopper JL. On why “common environment” effects are so uncommon in the literature. In: Spector T, Sneider H, MacGregor A, editors. Advances in twin and sib-pair analysis. London: Greenwich Medical Media; 1999. p. 151–65.
  24. ↵
    Lange K, Boehnke M. Extensions to pedigree analysis. IV. Covariance components models for multivariate traits. Am J Med Genet 1983;14:513–24.
    OpenUrlCrossRefPubMed
  25. ↵
    Lange K, Boehnke M, Weeks D. Programs for pedigree analysis. Los Angeles: UCLA Department of Biomathematics; 1987.
  26. ↵
    Kerlikowske K, Shepherd J, Creasman J, Tice JA, Ziv E, Cummings SR. Are breast density and bone mineral density independent risk factors for breast cancer? J Natl Cancer Inst 2005;97:368–74.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 14 (9)
September 2005
Volume 14, Issue 9
  • Table of Contents

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Is There Overlap Between the Genetic Determinants of Mammographic Density and Bone Mineral Density?
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Is There Overlap Between the Genetic Determinants of Mammographic Density and Bone Mineral Density?
Gillian S. Dite, John D. Wark, Graham G. Giles, Dallas R. English, Margaret R.E. McCredie and John L. Hopper
Cancer Epidemiol Biomarkers Prev September 1 2005 (14) (9) 2266-2268; DOI: 10.1158/1055-9965.EPI-05-0279

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Is There Overlap Between the Genetic Determinants of Mammographic Density and Bone Mineral Density?
Gillian S. Dite, John D. Wark, Graham G. Giles, Dallas R. English, Margaret R.E. McCredie and John L. Hopper
Cancer Epidemiol Biomarkers Prev September 1 2005 (14) (9) 2266-2268; DOI: 10.1158/1055-9965.EPI-05-0279
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Cancer Predisposition Gene Mutations and Pancreatic Cancer
  • Statin Use and Breast Cancer Risk
  • Tamoxifen and Longitudinal Mammographic Density Change
Show more Short Communications

Keywords

  • Mammographic density
  • bone mineral density
  • twin study
  • genetic epidemiology
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement